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Abstract—In an attempt to reduce the infection rate
of the COrona VIrus Disease-19 (Covid-19) countries
around the world have echoed the exigency for an
economical, accessible, point-of-need diagnostic test to
identify Covid-19 carriers so that they (individuals who
test positive) can be advised to self isolate rather than
the entire community. Availability of a quick turn-
around time diagnostic test would essentially mean
that life, in general, can return to normality-at-large.
In this regards, studies concurrent in time with ours
have investigated different respiratory sounds, includ-
ing cough, to recognise potential Covid-19 carriers.
However, these studies lack clinical control and rely on
Internet users confirming their test results in a web
questionnaire (crowdsourcing) thus rendering their
analysis inadequate. We seek to evaluate the detection
performance of a primary screening tool of Covid-19
solely based on the cough sound from 8,380 clinically
validated samples with laboratory molecular-test (2,339
Covid-19 positive and 6,041 Covid-19 negative) under
quantitative RT-PCR (qRT-PCR) from certified labo-
ratories. All collected samples were clinically labelled,
i.e. Covid-19 positive or negative, according to the
results in addition to the disease severity based on the
qRT-PCR threshold cycle (Ct) and lymphocytes count
from the patients. Our proposed generic method is
an algorithm based on Empirical Mode Decomposition
(EMD) for cough sound detection with subsequent
classification based on a tensor of audio sonographs and
deep artificial neural network classifier with convolu-
tional layers called ‘DeepCough’. Two different versions
of DeepCough based on the number of tensor di-
mensions, i.e. DeepCough2D and DeepCough3D, have
been investigated. These methods have been deployed
in a multi-platform prototype web-app ‘CoughDetect’.
Covid-19 recognition results rates achieved a promising
AUC (Area Under Curve) of 98.80%±0.83%, sensitivity
of 96.43% ± 1.85%, and specificity of 96.20% ± 1.74% and
average AUC of 81.08% ± 5.05% for the recognition of
three severity levels. Our proposed web tool as a point-
of-need primary diagnostic test for Covid-19 facilitates
the rapid detection of the infection. We believe it
has the potential to significantly hamper the Covid-19
pandemic across the world.
I. Introduction
The COrona VIrus Disease-19 (Covid-19) is an in-
fectious disease caused by the newly discovered severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-
2). Covid-19 bears stark similarities with the Severe
Acute Respiratory Syndrome (SARS) as well as the com-
mon cold. According to the World Health Organization
(WHO), the mild symptoms of Covid-19 can include fever,
cough and shortness of breath akin to the common cold
[1]. Like SARS in more severe cases, Covid-19 also causes
pneumonia and/or significant breathing difficulties, and
in some rare instances, the disease can be fatal with the
overall mortality rate estimated to be 0.28% worldwide.
The initial cases of Covid-19 were initially diagnosed as
pneumonia on 31 December 2019, and later re-diagnosed
as Covid-19.
Covid-19 has proven to be a very infectious disease
with the virus (SARS-CoV-2) spreading quickly on coming
in close contact with an infected person (mean infection
rate of 2.5). More specifically, according to the WHO,
the (Covid-19) virus is transmitted through direct contact
with respiratory droplets of an infected person (generated
through coughing and sneezing) [2]. The WHO declared it
a global pandemic on 11 March 2020, within three months
of first reported cases in China.
Covid-19 has put considerable strain on the health sys-
tems worldwide, with even developed countries struggling
to test enough people to stop its spread effectively. Hence,
taking the Covid-19 pandemic context in consideration, it
is important to re-think the classical approaches for timely
case finding [3], as well as to utilise the limited resources
available most effectively [4].
In past pandemics, such as Malaria, a two pronged
approach for a screening test was successfully employed
to combat the spread of a prevalent virus [5]. In these
two-stage strategies, the primary stage focuses on greater
accessibility and ease of screening that is cost-effective.
The primary stage is to ‘alert’ a potential carrier if they
test positive on a primary screening test. In most cases,
only those who test positive on the primary test go on
to the secondary test, hence reducing the burden on the
health system, and making the most of the resources
available to conduct the secondary test. The secondary
screening is where the null hypothesis that the participant
is not carrying an infection is accepted or rejected. The
current techniques employed for screening of Covid-19 use
serology, and diagnosis is based on the presence of genetic
material of the virus. Clinical molecular tests have robust
diagnostic accuracy but require specialised equipment, as
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well as trained personnel to conduct the test. The turn-
around time of these tests can vary from hours to several
days.
Given the established success of two-pronged screening
mechanisms to hamper the spread of infectious diseases,
in this work, we aim to develop a web-based tool for
the primary screening of Covid-19. The motivation is to
identify Covid-19 carriers using a model trained with
clinically validated cough signals since Covid-19 affects
the respiratory system [6]–[8]. Established works have
evidenced the possibility of using the latent sound charac-
teristics of coughs to identify respiratory diseases [9], [10].
In addition, prior works have also reported that voluntary
coughs (asymptomatic) contain sound characteristics that
allow detecting abnormal pulmonary functioning and res-
piratory diseases [11], [12].
The remainder of this paper is structured as follows:
section II outlines a summary of contributions, section III
gives an overview of related work; section IV describes the
procedural and methodological stages of the development
of this technology; section V evaluates the recognition and
assessment results; section VI discusses the results and
achievements; with conclusion in section VII.
II. Summary of contributions
The main contributions of this work are manifold and
listed as follows:
1) The proposed method ‘DeepCough’ achieves high
accuracy, without the necessity of using specific pre-
trained models or transfer learning of data from
other studies. Hence, differently from related work,
the proposed methodology is generic, paving
the way for derivative works.
2) In contrast to related work, we are able to evaluate
the real capacities of detecting Covid-19 in a large
clinically validated dataset (8,000+) where all data
samples are matched with molecular-test of
Covid-19 viral infection dispensed in certified
laboratories to participants.
3) Also unique to this work, the accompanying
molecular-tests (qRT-PCR) along with the cough
samples, allow us to predict as well the extent
of the infection. This is studied in this work using
either the cycle threshold (Ct) from the qRT-PCR
test or lymphocyte counts.
4) Furthermore, a full-stack automatic processing
framework, from a raw sound stream to the
test results, is also presented.
5) Development of a tangible test service proto-
type, as a platform-independent web-app service,
CoughDetect.com1
III. Related Work
In an attempt to better understand the Covid-19 infec-
tion, and its associated symptoms, scientists have been
1https://coughdetect.com
collecting a wide spectrum of information in the latest
months. This includes, but is not limited to, the respi-
ratory sounds related to Covid-19 [6] [8] [13], thermal
imaging [14], digestive symptoms [15], as well as self
reported surveys. The motivation of collating Covid-19
related information is to develop robust mechanisms for
early detection of Covid-19. The most common symptoms
of Covid-19 have been linked to pneumonia (cough, fever,
shortness of breath, among others). Therefore, the analysis
of cough audio signals is considered a viable course of
action for a primary Covid-19 diagnosis [8].
In general, three different respiratory sounds have been
investigated to detect Covid-19 in patients: voice, breath
and cough. The voice is a bio-signal that has been studied
for many years to decode emotional, mental and physical
aspects of a speaker. Usman et al. [16] conclude that
there is a strong correlation between speech and Covid-
19 symptoms, and therefore endorse the usage of speech
signals for detecting Covid-19.
Faezipour et al. [17] recommended the use of signal pro-
cessing techniques in tandem with state-of-the-art machine
learning and pattern recognition techniques for prelimi-
nary diagnosis of Covid-19 from breathing audio signals.
However, neither of the studies [16] and [17] encompass
the Covid-19 recognition at this stage, with the additional
caveat of quality of breath sounds hinged on the sensitivity
of the microphone.
Another notable work on breathing patterns is done by
Wang et al. [18] who developed a respiratory simulation
model (RSM) for detecting the abnormal respiratory pat-
terns of people remotely, and unobtrusively using a depth
camera. However, their proposed RSM did not incorporate
data from Covid-19 carriers. Nevertheless, the use of video
cameras may raise privacy concerns. Imran et al. [19]
presented AI4COVID - an approach to classify coughs
using deep learning, and achieved an accuracy of 92.85%.
However, their dataset contains only 70 Covid-19 cough
samples, which renders their analysis to be inconclusive.
Sharma et al. [20] presented Coswara2, a database
embodying respiratory sounds (cough, breath, and voice).
This dataset is crowdsourced (volunteers from the web),
i.e. not clinically controlled samples, with only eight posi-
tive Covid-19 samples at the time of writing of this study.
Here, it is also important to note that sound modalities,
especially voice, embodies privacy concerns since an in-
dividual can be identified from their voice [21]. Other
notable database creation projects collecting data from the
web include: Opensigma3 by MIT collects collecting cough
samples, Corona Voice Detect4 by Voca.ai and Carnegie
Mellon University (CMU) is collecting voice data, Covid
Voice Detector5 also by CMU is collecting further voice







University of Cambridge is collecting crowdsourced sam-
ples of voice, cough, and breath.
A consensus derived from the related work referenced
above is the challenge associated in the collection of clin-
ically validated Covid-19 data which can be subsequently
used for the training of Covid-19 recognition mechanisms.
Towards this end, the data used in this study is collected
following a strict protocol designed at laboratories and
hospitals dedicated to Covid-19 diagnosis by expert im-
munologists. Another major strength of our proposed web-
based app CoughDetect lies in the anonymity of the users.
Coughs sounds are inherently anonymous. Collecting just
cough sounds, along with the usage of in-house code only
and strict privacy-preserving practices, we have ensured
that participants share their cough samples without expos-
ing their personal information. This robust quality control
of our collected samples is an advantage of our work with
respect to other studies, e.g. collecting clinical data via
web questionnaires (crowdsourcing).
IV. Methods for developing a point-of-need
Covid-19 web-app service from only cough sound
samples
The cough samples are collected by means of an in-house
developed web app named CoughDetect. The CoughDe-
tect app (https://coughdetect.com) can be easily used
with a laptop, mobile phone, or tablet, as shown in
Fig. 1. The development of the whole stack for Covid-19
primary screening required the use of several technologies
to capture, process, analyse and make the test available.
An illustration of the proposed technology stack diagram
for the CoughDetect operational architecture is shown in
Fig. 2. The app records (.wav) sound files at 44,100Hz
sample rate and transfers them to a secure data server
using HTTP over SSL connection.
The three stages of the development stack include:
1) Sound stream processing and Detection;
2) A recognition method based on the generation of an
Acoustic Cough tensor and Deep Learning (Deep-
Cough);
3) Development and Deployment of the framework in a
Web Tool App (CoughDetect).
A flow chart delineating the steps in the inference mech-
anism of DeepCough is shown in Fig. 3. The pre-processing
of the raw sound signals is done to increase the signal-to-
noise ratio and reduce the signal size. Cough bursts are
detected in the recording and the rest of the signal is
discarded. A set of low-level acoustic descriptors (a.k.a.
sonographs) are extracted from a pre-processed cough
sound. Two- and three-dimensional (2D and 3D) tensors
are generated from these descriptors. These tensors are fed
to a convolutional deep neural network that allows classi-
fication of positive and negative Covid-19 cough samples.
Additionally, positive patients are sub-classified according
to severity: borderline positive, standard positive, high
positive based on qRT-PCR values and lymphopenia, or
normal lymphocytes based on their blood lymphocyte
count, as shown in Fig. 3. Further details of research ethics
and the different stages for building the CoughTensor and
classification are presented next.
A. Research Ethics and Protocol
The collection of clinically validated cough data was
carried out in collaboration with Hospital Costa del Sol
Health Agency in Málaga, Spain and the National Labora-
tory for Research in Food Safety (LANIIA) laboratory in
Nayarit, Mexico. The collection of the data started at the
peak of the pandemic in Spain and Mexico on the 4th of
April 2020 and lasted until the 21st of September 2020.
The clinical protocols and research ethics are approved by
the respective local institutional ethics committees (Code:
BIOETIC_HUM_2020_02, Mexico; Code: APP_Covid-
19_03042020, Spain). The Nayarit Unit and Málaga hospi-
tal are both accredited centres for the molecular diagnosis
of Covid-19 and are also ISO 9001 certified.
The cough samples are collected from patients coming
to the named institutions for a qRT-PCR test for detection
of SARS-Cov-2 (Covid-19) by registered nurses trained
to use the CoughDetect app. At all stages of the cough
sample collection, the guidelines to interact with potential
Covid-19 patients recommended by the WHO are strictly
followed. For instance, the nurse wears personal protective
equipment at all times, and a protocol for the smartphone
disinfection, each time a cough is recorded, is observed.
The user interface and control functions of the Web
App have been developed with in-house code to uphold
the anonymity of the users and minimise the possibility
of information leakages to external entities. This is in
conformity with both the EU General Data Protection
Regulation (GDPR) and the UK Data Protection Act
2018. In addition, our research and application also meet
the ethical standards of the Declaration of Helsinki. A
written informed consent was collected from each partic-
ipant prior to acquiring their data sample. Clinical data
was collected for this study by healthcare professionals.
Table I, Fig. 4 summarises the demographic ratios and
factors such as the number of days after first symptoms
reported. In total, we collected n= 8,380 coughs, of which
2,339 coughs are from patients with a positive qRT-PCR
(a) Mobile Phone (b) Laptop (c) Tablet
Fig. 1: The CoughDetect app can be easily used with a













COVID-19 Anonymous Cough Test
Fill in the Form
If you have tested positive for coronavirus, you can still help us to fight this
pandemic from home by providing us with just a sample of your cough sound.
By pressing the red button labelled as Record below, you give your consent for us to
save your cough sound, sex and age for this study
Our collected data is ANONYMOUS and this simple app does not use any method to
track users, geolocation or browsing cookies.
Furthermore, we don't use third party web services to run this minimal app, such us
the ones provided by Google Inc, Wix or Squarespace.
Please enter the approximate days since you started feeling symptoms






















Fig. 2: A user can record his cough sample using the CoughDetect web or mobile app with complete anonymity. The
user’s cough sample is then analysed by DeepCough (the inference mechanism of CoughDetect) for primary screening of
Covid-19. A user can receive one of the following two messages on successful analysis of his cough sample: ∗Your cough
sound shares similarities to those of Covid-19 patients, if you are a high-risk individual, please contact
health services immediately, otherwise quarantine yourself. †Our system does not recognise your pattern as
similar to those with Covid-19 in our database, still if you feel the most likely symptoms, please contact
health services.




























Fig. 3: The overall flow diagram delineating the steps involved in the DeepCough, 2D and 3D, inference mechanism.
test and 6,041 coughs are from patients with a negative
qRT-PCR test. Of those patients who resulted negative in
the qRT-PCR test, 47.46% had no symptoms, and 52.54%
had symptoms, at the time of taking the samples. Of
those patients who resulted positive in the qRT-PCR test,
20.00% had no symptoms, and 80.00% had symptoms, at
the time of taking the samples.
B. Cough sound pre-processing and detection
Cough samples (.wav) are were acquired at 44.10 kHz,
Pulse-code modulation (PCM) format, monochannel. The
raw sound data is low pass filtered with a cutoff frequency
of 1 kHz. A Chebyshev type-2 second order filter with a
transition frequency of 10Hz is applied to retain the high
TABLE I: Demographic statistics of the data (Covid-19
positive and negative patients)
Positive Negative
Measure Age Days∗ PCR CT Age Days∗ PCR CT
Mean 39.44 7.74 29.21 38.74 7.90 40.23
Median 38 7 31 38 6 41
Std. Dev. 14.24 6.39 7.13 13.59 6.67 6.16
Max 79 60 37 79 50 43
Min 7 1 18 7 0 38
∗number of days since the onset of symptoms
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Cycle Threshold Sample Distribution























Patient Age Sample Distribution







































Patient Age Sample Distribution
a) Density Distributions for positive samples. b) Positive samples c) Negative samples
Fig. 4: a) Density distributions of cycle threshold (Ct), lymphocyte count, age, and days from first symptoms from
the samples of Covid-19 positive patients. b) Percentage ratios of sex (Male, Female, and Not Specified) and level
of positivity (Borderline Positive, Standard Positive, and High Positive) of samples from positive Covid-19 patients
displayed in pie charts. c) Percentage ratios of sex (Male, Female, and Not Specified) of samples from negative Covid-19
displayed in a pie chart along with density distribution of age for Covid-19 negative patients.
pitch sound of cough while attenuating background sounds
simultaneously. Before cough detection, the filtered sound
signal is decimated. For an initial bout of sounds in the
recording, such as initial involuntary voice before cough-
ing, envelope analysis detects the first peak amplitude and
the following signal is subsequently trimmed.
The cough detection algorithm with the filtered audio
signals is based on empirical mode decomposition (EMD)
[22], [23]. EMD is a fully data-driven signal processing
technique that does not employ base functions. EMD splits
a sequence into a set of smaller sequences, referred to as
intrinsic mode functions (IMFs), or simply modes, whereby
each mode contains the energy associated at a certain
scale. EMD has become popular in many applications, e.g.
wearable sensors [24], perhaps because the decomposition
occurs in the same space as the original sequence.
EMD is applied to find the modes that better reflect the
coughing periods. These periods are empirically selected to
essentially detect cough burst in the filtered sound record-
ings. Individual or a set of IMFs can be objectively used for
signal filtering, peak detection and signal reconstruction.
For cough detection, depending on the noise level of the
signal, certain IMFs contain rich information related to the
peaks associated with coughs. Based on testing a number
of signals with various noise levels, the 5th and the 9th
modes are found as the prime IMFs essential for detection.
The instantaneous amplitudes (IAs) of the selected
modes (5th and 9th) are calculated by the Hilbert Trans-
form [22]. The IAs of the selected modes are averaged,
low pass filtered using a median filter with a window
size of 500 signal samples, and normalised. Thresholding
is performed using local signal peak detection: A signal
sample is a local mode or peak if it has the local maximal
value being preceded (to the left) by a value difference of
∆≥ 0.006. Thresholding the processed IAs partitions the
original signal into cough and non-cough burst event. A
summary of the EMD based algorithm for cough detection
is depicted in Fig. 5.
The detection algorithm produces a sequence of binary
values: ones for cough and zeros for non-cough segments.
A post-processing step joins consecutive cough bursts
(segments) which are part of a single or main cough. To do
this, an additional threshold is specified to decide whether
to join neighbouring cough bursts with a distance shorter
than 1500 decimated signal samples (0.34 seconds). Once
an entire cough sound is detected, the rest of the signal is
discarded. In addition, segments of short duration (length
less than 400 signal samples) were discarded as they were
often found to be more representative of short spikes in the
signals due to ambient noise rather than part of a cough
sound. The final output is a vector of indices that indicates
where a cough in a raw sound stream is found.
C. A CoughTensor of Sonographs
Following detection, the information contained in the
audio signals is transformed into a tensor form. We focused
on representations that capture the main acoustic prop-
erties of the coughs. We used three types of sonographs:
1) Mel-frequency Cepstral Coefficients (MFCCs), 2) Mel-
scaled spectrogram (MelSpec), and 3) Linear Predictive
Coding Spectrum (LPCS) coefficients. These sound rep-
resentations have specific properties for classification in
intelligent audio analysis. We describe them here and
discuss what they can inform us about coughs sounds.
1) Mel-frequency Cepstral Coefficients: MFCCs take
into account human auditory perception, where low fre-
quencies are better understood than high frequencies. The
frequency bands are logarithmically located according to
the Mel scale, which simulates the human auditory re-
sponse more appropriately than the linearly spaced bands
while at the same time disregards all other information.
This descriptor is robust to variations in speech across
subjects as well as the variations in recording conditions.
MFCCs have been widely used in frequency domain speech
recognition [25]–[27]. The computation of MFCCs involves
the following main steps: (i) blocking of pre-processed
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Fig. 5: A pictorial illustration of the steps involved in the detection algorithm.
cough sounds into overlapping windows to avoid loss of
information at the ends of windows, (ii) applying ham-
ming window on each frame to taper ends of a frame
to zero so that spectral leakage can be avoided during
the implementation of Fourier Transformation (FT), and
(iii) computation of the power spectrum by applying FT.
Next, (iv) the computed spectrum is passed through Mel-
spaced band pass filters, where each filter provides the sum
of energy for each frame. Finally, (v) the application of
discrete cosine transformation yields MFCCs.
2) Mel-scaled Spectrogram: The MelSpec is a sonograph
where frequencies are converted to the Mel scale in order to
visually assess the energy distribution in the signal. The
distribution of the energy in the Mel-based spectrum is
relevant for the detection of Covid-19 positive samples.
Fig. 6 provide examples of the energy spectrum for positive
and negative samples. It can be observed that when a
Covid-19 patient starts coughing, the energy is in the low-
frequency region. However, over time the energy shifts to
the high-frequency region. The lower frequencies at the
start may be due to pain, and later perhaps the extra ef-
forts required for coughing make the signal more irregular
and complex over time. A similar trend is also observed
in the voice of people who are suffering from pain due
to vocal folds disorders. Extra efforts in speaking render
the signal complex which result in an irregular spectrum
(continuous voice breaks and disperses energy) compared
to a healthy person [28], [29]. In contrast, for a Covid-
19 negative person, the energy is uniformly distributed
among all frequencies. Therefore, the stark differences in
MelSpecs from Covid-19 positive and negative individuals
can be leveraged for successful identification of Covid-19
infection.
3) Linear Predictive Coding Spectrum (LPCS) coeffi-
cients: LPCS models the emission source of an acoustic
signal. LPCS is based on the source-filter model of phona-
tory signals. It is frequently used for the processing of
speech and infant cry. Linear predictive coding analysis
estimates the values of a signal as a linear function of
previous samples. LPCS is a simplified vocal tract model
that reflects the speech production system using a source-
filter model. LPCS derives a compact representation of
the spectral magnitude of brief duration signals (e.g.
coughs). Its parametric analysis allows more accurate
spectral resolution than the non-parametric FT when the
signal is stationary for only a short time [30]. This sound
representation has been used for assessing the vocality
of cough sounds [31] and detecting coughs from other
human sounds [32]. For each audio frame, we extracted
MFCCs with 33 coefficients, MelSpec with 33 bands,
and LPCS with 33 line spectral pair frequencies from 33
coefficients. We obtained three matrices of 33 columns
by the number of frames of the audio sample. The three
sonographs are stacked to form a three-dimensional tensor.
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Since cough samples have different durations, they have
different number of frames. For all samples, the tensor
is padded with zeros to complete 100 x 33 x 3 matrices
(see Fig. 3) to obtain matrices of the same shape before
passing them to the training stage. We set a sampling
rate of 22050 and a hop length of 512. The 100 frames
are equivalent to around 2.3 seconds. We chose this tensor
length as the minimum duration of a cough event after
pre-processing and detection (section IV-B) falls in this
range. Additionally, using this length we ensure that no
spurious noise is included in the audio input.
D. Classification of the CoughTensor via Convolutional
Neural Networks ‘DeepCough’
The CoughTensor generated in Section IV-C are input
to a stack of convolution blocks. Fig. 7 illustrates the
architecture of DeepCough along with the dimensions of
each layer. The sonograph tensor is fed to the convolution
blocks in a manner analogous to how RGB images are pro-
cessed. The first dimension corresponds to the horizontal
axis of the sonograph (time frames), the second dimension
is the vertical axis (frequencies, bands, coefficients), and
the third dimension is the type of sonograph. For compar-
ison purposes we defined two types of DeepCough:
1) DeepCough2D: The CoughTensor where 2D Mel-
Spec is included in the tensor only, making a tensor
spanning two dimensions (frequency and time) i.e.
100×33×1.
2) DeepCough3D: The CoughTensor stacks all sono-
graphs described in section IV-C, with additional
Fig. 6: Energy contours of the Auditory Processed Spec-
trum (APS) representation which is related to MFCCs [29]
(a-c) Covid-19 positive patients (d-f) Covid-19 negative
persons. Darker colors represent lower energy in the spec-
trum, while lighter color means higher energy.
third dimension added for each sonograph hence
rendering a tensor size of 100×33×3.
Each convolutional block is composed of the following
layers:
• Convolutional layers with rectifier linear units
(ReLU): Convolution window is set to 2 × 2
(height/width) and initial padding is set to the length
of the input tensor. The input dimensions are row,
column and channels.
• Max pooling layer: The pooling window is also set to
2×2 for height and width.
• Dropout layer: A drop out level of 20% probability in
each block to deter the model from over-fitting.
This basic block is stacked four times, permitting a
balance between architectural depth and complexity. The
stack is followed by subsequent layers to transform the
intermediate layer outputs for the final layer:
• A global average pooling layer (GA): It averages all
spatial dimensions of the input tensor until the spatial
dimension is one.
• Dense layer (D): A dense layer yielding an output
equivalent to the number of classes (one per class).
• Softmax layer: A softmax type action function that
performs classification over the inputs.
Adaptive Moment Activation (ADAM) is the optimiser
used to train the network with a categorical cross-entropy
loss function. The evaluation metric during training for
ADAM is the sum between resultant area under the
curve (AUC) and balanced accuracy. The entire model is
implemented in Keras [33] with Tensorflow backend.
The remarkable classification prowess of DeepCough
arises from representation learning via convolutional neu-
ral networks of the sonograph representations. It is not
only an intuitive approach for the analysis of pattern
singularities in cough sounds but also has the capacity to
integrate information from different sonographs, therefore
jointly performing pattern analysis in the information that
comes to represent emission (MFCCs, MelSpec) and per-
ception characteristics (LPCS) of sounds (section IV-C).
E. Development and Deployment of DeepCough as an
Anonymous Web-based primary screening for Covid-19
The methods described in this paper are deployed in
a Web App proof of concept (POC) available at https:
//coughdetect.com. The main objectives of the interface
are as follows:
• Enable a sleek and multi-platform Web App that can
be accessed from any device with connectivity to the
Internet without installation i.e. like accessing any
other Web page.
• Capable of running without the use of session cookies
(page reload) or third party services to ensure pa-
tient’s anonymity is upheld.
• Interaction with user-server should be one-off and
response. Multiple interactions with the server are




















(a) The architecture of CNN.
Block Number Layer Name Output Shape Learning Params.
Block 1 (B1)
Convolution + ReLU (32, 99, 16) 208
MaxPooling (16, 49, 16) n/a
Dropout (0.2) (16, 49, 16) n/a
Block 2 (B2)
Convolution + ReLU (15, 48, 32) 2080
MaxPooling (7, 24, 32) n/a
Dropout (0.2) (7, 24, 32) 0
Block 3 (B3)
Convolution + ReLU (6, 23, 64) 8256
MaxPooling (3, 11, 64) n/a
Dropout (0.2) (3, 11, 64) 0
Block 4 (B4)
Convolution + ReLU (2, 10, 128) 32896
MaxPooling (1, 5, 128) n/a
Dropout (0.2) (1, 5, 128) n/a
GA Global Averaging (128) n/a
D Dense (2 ) 258
(b) Summary of the CNN’s architecture.
Fig. 7: (a) An illustration of the architecture of the Convolutional Neural Network (CNN) with (b) dimensions of
convolutional blocks (B1-B4), max-pooling layers, a global averaging (GA), and a dense (D) layer.
The use of MERN (MongoDB, ExpressJS, ReactJS,
NodeJS) stack enables a true separation of layers allowing
flexible control over each front-end and back-end compo-
nent as depicted in Fig. 2. React fundamentally uses SPA
(Single Page Application) approach to quickly load a single
resource (index.js) that contains the entire application
rather than sending HTTP requests to the server every time
a user wants to navigate elsewhere within the app. Not
having to reload the page disables the need for storing
cookies in the user machine that can be used to re-identify
the user. The front-end logic is mainly javascript code
that will be run in the client machine.
Functional interaction, such as recording the cough,
passing it over to the server for evaluation and receiving
feedback, is done using a custom-built self-hosted API
instance solution on a different port. Connections to the
server are always encrypted using Hypertext Transfer
Protocol Secure (HTTPS). Locally, in the server machine,
the node.js endpoint interacts with a python-based API
that implements the algorithms and methods from sections
IV-B to IV-D. Once the server receives an audio stream,
the processing pipeline is activated, a prediction of the
test is issued, and an asynchronous message is returned
to the user (client), through the same established secured
connection, to update the Web App with the result of the
test as illustrated in Fig. 2.
V. Results and Evaluation
In this section we present A) the recognition results of
DeepCough for the detection of Covid-19 vs non-Covid-
19, and B) further categorisation of the Covid-19 positive
samples into groups indicating the grade of Covid-19
disease, with respect to qRT-PCT and lymphocyte counts
separately. A comparison of our proposed method Deep-
Cough3D with approaches in related work (AI4COVID
[19], Coswara [20]) and Cough against Covid [34]), as well
as Auto-ML [35] is also presented.
A. Evaluation of Covid-19 Detection with DeepCough
The classification results are reported for a stratified
k = 10 cross-folding replication strategy for internal valid-
ity. A sample can only be exclusive member of one fold.
In each iteration a disjoint fold is left out for testing, a
different one for validation and the remaining are used for
training. The confusion matrix for DeepCough3D, shown
in Table III, demonstrates the classification prowess of
DeepCough3D with true positives at 97.18% and true
negatives at 96.64%.
We also compare our proposed method with approaches
in related work as well as AutoML [35]. AutoML is a full
model meta-learning algorithm that combines Bayesian
optimisation in a set of shallow machine learning algo-
rithms, such as k-nearest neighbours, naïve Bayes, sup-
port vector machines, decision trees, random forest, and
boosted classifiers. Auto-ML uses Bayesian optimisation of
the AUC score to find for a method or their combinations
(viz. pipelines), as well as the model hyper-parameters
that yield the highest classification performance as de-
lineated in Fig. 8. It further considers feature selection
through information gain, relief, χ2 statistics. The Auto-
ML method is trained with flattened vectors of audio
signal descriptors (Mel-Frequency Cepstral Coefficients,
Zero-Crossing Rate, Roll-Off Frequency, and Spectral Cen-
troid).
Models were implemented in Python and trained on an
Ubuntu Linux machine with AMD(R) Threadripper(R),
3.40GHz processor and 32 GB of RAM. Training time in
this machine for 10-folds of the DeepCough approach was
∼ 35 minutes. We further deployed the trained models in
an Oracle cloud virtual machine with eight cores (CPU
only) as the back-end of the Web app (section IV-E. In
this setting, the detection of a cough in a sound stream
lasts in the range of 6-12 seconds and the results of the
test are issued in 1-2 seconds.
Performance comparison of DeepCough 2D and 3D
vs other related approaches and Auto-ML in terms of
statistical measures of AUC, precision, sensitivity, and
specificity are listed in Table II. A bar graph of the same
results is shown in Fig. 9 (a) for a visual comparison. In
Fig. 9 (b) the recognition performance of DeepCough3D is
primarily assessed in terms of the AUC since AUC allows
considering both sensitivity and specificity for different
cut-points and gives a better view of the benefit of the
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Fig. 8: Flowchart outlining the model selection process with Auto-ML [35].
than positives, than standard accuracy. All of the above
results conclude that DeepCough 3D approach afforded
the highest significant performance rates in most statistics
for the classification of Covid-19 positive vs negative cough
samples.
B. Assessing the grade of infection from Covid-19 positives
samples
In this study, alongside the cough samples, we also
collected the outcomes from quantitative real time poly-
merase chain test (qRT-PCR) and lymphocyte count (blood
ratio) tests. qRT-PCR test is currently considered the gold
standard for detecting a positive Covid-19 infection. qRT-
PCR test detects the (Covid-19) virus’ RNA within a
patient’s genetic material. In qRT-PCR test, the RNA is
reverse transcribed to DNA using specific enzymes. Addi-
tional short fragments of DNA, that are complementary
to transcribed viral DNA, are then added. Some DNA
strands are programmed to release a fluorescent dye. The
amount of fluorescence is monitored in each cycle, until a
threshold is surpassed. The fewer the cycles (Ct) it takes
to surpass this threshold, the higher the severity of the
infection. During the Covid-19 pandemic, a challenge is
to identify patients with low and mild levels of infection
or asymptomatic, so called ‘carriers’ [36]. Regardless of
their asymptomatic conditions, positive qRT-PCR detec-
tion can be done with an adequate sample pooling to deal
with potential borderline Ct values from these patients
[37]. For this experiment, we labelled a cough sample in
terms of whether it came from a patient whose Ct values
were borderline positive (30 ≤ Ct < 35), standard positive
(20 ≤ Ct < 30) or strong positive (Ct ≤ 20).
The performance results for the recognition of the cough
sample using DeepCough2D and DeepCough3D are dis-
played in Fig. 10a and enlisted in Table IV. Overall,
performance results show a recognition rate well above
chance level and average AUC of 81.08% ± 5.05% for
DeepCough3D. This can potentially be helpful to support
two-stage screening protocols previously discussed in the
introduction. The recognition of the disease severity was
better at discriminating samples coming from the highly
discerning groups, i.e. borderline and high positive, but
struggled with the intermediate group. This is, however
expected as intermediate samples can have a mixed pat-
tern of cough acoustics to those loosely or highly affected.
Nevertheless, its specificity was highly better than for the
two other groups.
Another marker of disease severity that we have ex-
plored is lymphocyte count (viz. lymphopenia vs normal
levels of lymphocyte counts). Lymphopenia is a condi-
tion defined as when patients have a blood lymphocyte
percentage (LYM%) lower than 20%. Lymphopenia is the
frequency associated with a severe infection or illness. The
performance results from the recognition of lymphopenia
vs normal levels of lymphocytes are graphically displayed
in Fig. 10b. Although some works have suggested lym-
phocyte count as a way to grade Covid-19 severity [38],
our results to predict an infection grade using this marker
are not as good as when labelled by the qRT-PCR test.
However, the performance of DeepCough3D could also be
hampered, at this occasion, by subset levels of lymphocyte
counts that can be affected by biological and inter-subject
variabilities [39], [40].
VI. Discussion
The Covid-19 pandemic has proven difficult to contain
not only because of its high infection rate, but also because
the symptoms of Covid-19 borne stark similarities with
other viruses such as the common-flu and pneumonia.
Hence, it has been particularly challenging for carriers
of Covid-19 to know that they have been infected by
Covid-19, therefore furthering the spread of Covid-19.
To facilitate the early detection of Covid-19, we have
developed a test from clinically validated Covid-19 positive
and negative individuals that provided a cough sample and
performed a molecular-based test in certified laboratories.
This is a multi-center study, with populations from
Spain and Mexico, to ensure the trained inference mecha-
nism of DeepCough3D is unbiased towards particular de-
mographic characteristics. In addition, the proposed Deep-
Cough3D model, subsequently embedded in CoughDetect
for recognition of Covid-19 coughs, was compared against
related work and Auto-ML [35]. AutoML is a method
for algorithm selection and hyper-parameter tuning, opti-
mised through a full model selection strategy. In all the
performance metrics for Covid-19 positives recognition,
DeepCough3D performed better, as noted in Table II.
The reported results reaffirm that DeepCough3D learning
method used is successful in distinguishing between Covid-


































Comparison of DeepCough3D with DeepCough2D 




(a) Comparison of DeepCough 3D and 2D Classifiers with an
Auto-ML ensemble of shallow machine learning methods [35]
combined.
(b) Receiver Operating Characteristic curve for DeepCough and
other methods in related work as a function of true and false
positive rates.
Fig. 9: a) Statistical metrics comparison of DeepCough with the other best and worst methods tested. b) Receiver Operating
Characteristic (ROC) for DeepCough and other methods to detect pulmonary infection (Covid-19) coughs vs. other type of
coughs using this study database.
TABLE II: A comparison of statistical performance measures of DeepCough3D with DeepCough2D, AutoML [35], AI4COVID
[19], Coswara [20], and Cough Against (vs.) Covid [34] for recognition of Covid-19 coughs. The p-values for t-test are statistically
significant (*: p < 0.05, **: p < 0.01 ) for the average of all statistical metrics (M1-M4) for DeepCough3D in comparison to other
methods. Likewise, the p-values for t-test for DeepCough2D are also reported.
DeepCough3D DeepCough2D
AUC (M1) Precision (M2) Sensitivity (M3) Specificity (M4) M1 M2 M3 M4 M1 M2 M3 M4
DeepCough3D 98.80 ± 0.83 96.54 ± 1.75 96.43 ± 1.85 96.20 ± 1.74 - - - - ** ** ** **
DeepCough2D 96.20 ± 1.18 89.87 ± 1.46 89.63 ± 1.57 86.55 ± 4.64 ** ** ** ** - - - -
AutoML 69.04 ± 17.50 78.28 ± 7.78 48.70 ± 23.71 63.26 ± 11.74 ** ** ** ** ** * ** 0.22
AI4COVID 92.36 ± 1.96 85.93 ± 2.87 85.87 ± 2.87 81.36 ± 4.31 ** ** ** ** ** ** ** **
Coswara 87.69 ± 3.86 84.08 ± 3.57 81.99 ± 5.47 83.45 ± 3.48 ** ** ** ** 0.33 0.14 0.16 0.32
Cough-vs-Covid 66.41 ± 4.23 76.04 ± 2.53 76.64 ± 2.28 67.00 ± 4.29 ** ** ** ** ** ** ** **
(a) Sensitivity (recall), specificity and f1-score for the classification of
positive cough samples labelled as borderline positive, positive and
strong positives based on qRT-PCR results by DeepCough2D and Deep-
Cough3D.
(b) Classification performance metrics for the recognition
of Lymphopenia vs normal lymphocyte counts in blood
sample.
Fig. 10: Statistical performance results for the recognition of possible markers of disease severity.
The performance of DeepCough3D for establishing
whether a given cough sample is from a Covid-19 positive
or negative patient is clinically sound as a primary test or
pre-screening with an AUC of 98.80 ± 0.83, a sensitivity
of 96.43%± 1.85%, and a specificity of 96.20%± 1.74%.
The strength of DeepCough3D lies in high recognition
performance over a large set of clinically validated cough
samples earmarked with molecular test. This resolutely
corroborates the informational potential of the latent au-









True Positive False Negative
Actual Positive97.18% 2.82%
2273 66
False Positive True Negative
Actual Negative3.36% 96.64%
203 5838
TABLE III: Normalized confusion matrix for DeepCough3D.
TABLE IV: Statistical metrics for the classification results of
positive cough samples labelled as borderline positive, standard
positive and strong positives based on qRT-PCR results by
DeepCough2D and DeepCough3D.
DeepCough Statistical Borderline Standard High Average
Model Metric Positive Positive Positive of 3 classes
DeepCough2D
AUC 77.05 ± 3.70% 77.95 ± 7.77% 80.2 ± 3.78% 78.4 ± 5.08%
F1-score 60.81 ± 7.48% 48.98 ± 11.29% 70.94 ± 4.41% 60.24 ± 7.73%
Precision 59.72 ± 6.90% 53.36 ± 11.05% 70.88 ± 4.51% 62.32 ± 7.49%
Sensitivity 62.51 ± 9.78% 46.81 ± 13.42% 71.17 ± 5.40% 60.83 ± 9.53%
Specificity 76.15 ± 5.17% 91.04 ± 3.74% 74.63 ± 4.87% 80.61 ± 4.59%
DeepCough3D
AUC 80.59 ± 5.71% 80.75 ± 5.34% 81.09 ± 4.11% 81.08 ± 5.05%
F1-score 64.37 ± 10.89% 52.15 ± 8.52% 72.3 ± 5.76% 62.94 ± 8.39%
Precision 65.44 ± 10.17% 56.37 ± 8.31% 70.23 ± 6.35% 64.01 ± 8.28%
Sensitivity 64.12 ± 13.21% 50.18 ± 12.35% 74.93 ± 7.22% 63.08 ± 10.93%
Specificity 83.47 ± 4.04% 90.22 ± 3.13% 72.56 ± 5.28% 82.08 ± 4.15%
disease such as Covid-19. The diagnostic sensitivity of the
gold-standard molecular test for Covid-19, i.e. qRT-PCR,
is 98% for nasopharyngeal swab tests, whereas for saliva
is 91% [41]. However, the reported averaged sensitivity
of commercial serological kits (e.g. based on lateral flow
immunoassays) for Covid-19 was only 65% average (49.0%
min. to 78.2% max.) [42].
VII. Conclusion
In this work, a primary screening test for Covid-
19 is proposed and assessed using clinically validated
cough samples of participants, who jointly performed a
molecular-test (qRT-PCR) in our partner hospitals. The
proposed test framework is powered by a generic cough
identification algorithm based in EMD and a recognition
method named DeepCough3D. This latter method gener-
ates a 3D audio tensor to leverage the strength of a con-
volutional neural network approach to identify the latent
characteristics in Covid-19 cough signals. The performance
of DeepCough3D attains an AUC of 98.80 ± 0.83, a
sensitivity of 96.43%± 1.85%, that is comparable to the
reported sensitivity (91%± 10%) of accelerated serology
tests based on saliva [43]. The proposed generic method
does not require using specific transfer learning models
or data from other studies, paving the way for derivative
works. The proposed approach outperforms related works
and other state-of-the-art methods. Further, the quality
of our clinically controlled and validated large dataset
increases our confidence in the validity of these results.
In addition to the development of a recognition test for
Covid-19 using coughs, this work further investigates the
possibility to recognise the extent of the Covid-19 infection
in Covid-19 positive participants. This is undertaken with
the qRT-PCR test and the lymphocyte count, and the
results greatly surpassed chance levels of performance,
indicating the feasibility of assessing severity to some
extend. Classification of the coughs in three severity levels,
defined by the resulting Ct of the molecular test for
Covid-19, yields an average AUC of 81.08%±5.05%. This
could potentially serve as an additional functional feature
to diagnose the extent of the Covid-19 infection in a
given Covid-19 carrier. This can help facilitate effective
management of healthcare facilities during a pandemic,
such as ventilators, which were in short supply during the
first wave of the Covid-19 pandemic around the world.
Furthermore, the entire framework has been embodied
as a web-app service available at CoughDetect.com. The
motivation for developing this alternative test based on
coughs is to have a fast turn-around for Covid-19 point-
of-need primary test to a) reduce the burden on specialised
personnel for clinical or secondary diagnosis of Covid-19,
b) to make the primary screening available to masses at
large from the comfort of their homes at negligible costs,
and c) the anonymity of the participants is kept at the
core by using in-house custom code to power the analysis
and recording only their cough sounds. It can also be used
as an electronic health certificate at public places such as
airports, and schools.
In the midst of a global pandemic, the significance of
our proposed point-of-need primary test, developed and
tested on clinically validated data, is paramount. Our
proposed primary test can mitigate the logistics, long turn-
around time, and cost of clinical diagnostic test of Covid-
19. For future works, parameter tuning of the sonograph
representations and complementary analysis of coughing
behaviours could be explored to investigate further im-
provements in performance. It would also be of interest to
investigate whether tracking of Covid-19 progression can
be done using DeepCough3D.
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